Does bleeding during the downregulation phase mean that the treatment is not successful?

Generally, downregulation is a medication used in the early stages of assisted reproductive technology to suppress the natural ovulation cycle of the ovaries, thereby achieving better controlled ovarian hyperstimulation. Whether bleeding after downregulation indicates failure mainly depends on the amount of bleeding. Light bleeding usually does not indicate failure; however, heavy bleeding may suggest unsuccessful downregulation. Detailed analysis is as follows:

If the bleeding after downregulation is light—less than the usual menstrual flow—and is caused by withdrawal bleeding from progesterone, it is typically one of the signs indicating successful downregulation. Additionally, criteria for successful downregulation also include the presence of multiple follicles of similar size, all less than 5 mm in diameter; blood levels of estradiol, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) all below normal reference values; and an endometrial thickness of less than 5 mm. These indicators collectively suggest effective suppression of follicular growth, laying a solid foundation for subsequent controlled ovarian stimulation and in vitro fertilization (IVF) procedures.

However, if the bleeding occurs around the expected menstrual period or involves a heavy flow similar to a regular menstrual cycle, it may indicate poor or failed downregulation. In such cases, a color Doppler ultrasound can be performed to assess the specific conditions of the follicles and endometrium to further determine whether the downregulation was successful. If the follicles are of uneven size or the endometrial thickness exceeds 5 mm, it may suggest that the downregulation did not achieve the desired effect.

During the IVF process, patients should closely monitor their physical responses and communicate promptly with their doctors to ensure smooth progress of the treatment.